FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 335:668-670 August 29, 1996 Number 9 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Blackburn, H. PubMed Citation

To the Editor: As participants in the Food Advisory Committee assembled by the Food and Drug Administration (FDA) to consider the petition for approval of Olestra submitted by Procter & Gamble, we have a view of the approval process and recommendation of the committee that differs from that presented by Dr. Blackburn (April 11 issue).¹

The review process for Olestra involved the consideration of data from more than 200 studies in animals and humans (involving tens to thousands of subjects per study) conducted over a period of 25 years under both controlled and "free-living" conditions. The studies were reviewed by . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Levine, J., Gussow, J. D., Hastings, D., Eccher, A. (2003). Authors' Financial Relationships With the Food and Beverage Industry and Their Published Positions on the Fat Substitute Olestra. Am. J. Public Health 93: 664-669 [Abstract] [Full Text]  
• Vuorio, A. F., Gylling, H., Turtola, H., Kontula, K., Ketonen, P., Miettinen, T. A. (2000). Stanol Ester Margarine Alone and With Simvastatin Lowers Serum Cholesterol in Families With Familial Hypercholesterolemia Caused by the FH-North Karelia Mutation. Arterioscler. Thromb. Vasc. Bio. 20: 500-506 [Abstract] [Full Text]  
• Kassirer, J. P., Angell, M. (1998). Losing Weight -- An Ill-Fated New Year's Resolution. NEJM 338: 52-54 [Full Text]